ARMO BioSciences to Present at the Leerink Partners Global Healthcare Conference
Redwood City, CA, February 3, 2016 — ARMO BioSciences, Inc., a clinical stage developer of immuno-oncology therapeutics, today announced that the company’s President and Chief Executive Officer Peter Van Vlasselaer, Ph.D. will present at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday,
Event: Leerink Partners 5th Annual Global Healthcare Conference
Date: Thursday, February 11, 2016
Time: 1:25 - 1:45 pm Eastern Time (10:25 – 10:45 am Pacific Time)
Location: Waldorf Astoria Hotel, New York, N.Y.
Webcast: A live audio webcast of the presentation can be accessed from the company’s website at http://www.armobio.com/news-events.php. A replay will be available for 14 days following the presentation.
About ARMO BioSciences
Founded in 2012, ARMO BioSciences is a clinical-stage company developing immunotherapies focused on multiple difficult-to-treat oncology indications. The company’s lead immunotherapy AM0010, a PEGylated form of recombinant human
Scott Ogg, PhD
Vice President Corporate Development and Operations